A Ten-Year Retrospective Review of Medical Records of Patients Admitted with Meningitis or Encephalitis at Five Hospitals in the United States Highlights the Potential for Under-Ascertainment of Invasive Meningococcal Disease
Pathogens · 2025
DOI: 10.3390/pathogens14100962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Julio Ramirez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Norton Infectious Diseases Institute, Norton Healthcare, Louisville, KY 40203, USA. Hauptthemen laut MEDLINE: Neisseria meningitidis, Encephalitis, Meningococcal Infections, Meningitis, Meningococcal. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer Inc, Pfizer Inc..
Abstract (Originalsprache)
Laboratory confirmation of invasive meningococcal disease (IMD) relies on detection of Neisseria meningitidis in a biological specimen. Clinical management guidelines for patients presenting with signs and/or symptoms of meningitis and encephalitis emphasize the need for appropriate specimen collection for laboratory testing. To explore the potential for IMD under-diagnosis, we reviewed medical records of patients admitted with signs and/or symptoms of meningitis or encephalitis at five hospitals in Louisville, Kentucky, in 2014 to 2023. Among 675 patients admitted with meningitis and/or encephalitis with cerebrospinal fluid (CSF) cultures who received antibiotics, 300 (44.4%) received antibiotics before CSF collection. Among 431 with blood cultures who received antibiotics, 133 (30.9%) received antibiotics before blood collection. Among 751 patients with CSF collected, 651 (86.7%) CSF specimens were tested using polymerase chain reaction (PCR) for N. meningitidis detection. No blood specimens were PCR-tested. These findings indicated that current standard-of-care practices may lead to IMD under-diagnosis. Since public health surveillance relies on IMD laboratory diagnosis, these findings highlight the potential for under-ascertained IMD by surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Norton Infectious Diseases Institute, Norton Healthcare, Louisville, KY 40203, USA.
- Global Vaccines Medical Affairs, Pfizer, Collegeville, PA 19426, USA.
- Evidence Generation and Medical Affairs, Pfizer, Collegeville, PA 19426, USA.
- Medical Evidence Group, Pfizer, Collegeville, PA 19426, USA.
ORCID-Profile: Julio Ramirez, Stephen Furmanek, Thomas Chandler, Lisa R Harper, Raffaella Iantomasi, Jessica V Presa, Jamie Findlow, Frederick J Angulo
Förderung
- Pfizer Inc
- Pfizer Inc.
Zitieren
APA
Ramirez, J., Furmanek, S., Chandler, T., Prado, J., Harper, L. R., Shen, S., Iantomasi, R., Presa, J. V., Ali, M., Findlow, J., Moïsi, J. C., & Angulo, F. J. (2025). A Ten-Year Retrospective Review of Medical Records of Patients Admitted with Meningitis or Encephalitis at Five Hospitals in the United States Highlights the Potential for Under-Ascertainment of Invasive Meningococcal Disease. Pathogens. https://doi.org/10.3390/pathogens14100962
Vancouver
Ramirez J, Furmanek S, Chandler T, Prado J, Harper LR, Shen S, et al. A Ten-Year Retrospective Review of Medical Records of Patients Admitted with Meningitis or Encephalitis at Five Hospitals in the United States Highlights the Potential for Under-Ascertainment of Invasive Meningococcal Disease. Pathogens. 2025. doi:10.3390/pathogens14100962
BibTeX
@article{Ramirez2025,
author = {Ramirez, Julio and Furmanek, Stephen and Chandler, Thomas and Prado, Josue and Harper, Lisa R and Shen, Steven and Iantomasi, Raffaella and Presa, Jessica V and Ali, Mohammad and Findlow, Jamie and Moïsi, Jennifer C and Angulo, Frederick J},
title = {A Ten-Year Retrospective Review of Medical Records of Patients Admitted with Meningitis or Encephalitis at Five Hospitals in the United States Highlights the Potential for Under-Ascertainment of Invasive Meningococcal Disease},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14100962}
}
EUVIMED